Turn Therapeutics (TTRX) Invested Capital (2024 - 2026)

Turn Therapeutics' Invested Capital history runs 3 years deep, the most recent figure standing at $13.1 million for Q1 2026.

• In Q1 2026, Invested Capital rose 1502.22% year-over-year to $13.1 million; the TTM figure through Mar 2026 stood at $13.1 million (up 1502.22% YoY), while the FY2025 annual figure was $7.7 million, up 4448.21% from the prior year.
• Invested Capital was $13.1 million for Q1 2026 at Turn Therapeutics, up from $7.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $13.1 million in Q1 2026 to a low of -$414299.0 in Q3 2024.
• Historically, Invested Capital has averaged $3.6 million across 3 years, with a median of $661364.5 in 2025.
• Biggest YoY gain for Invested Capital was 4448.21% in 2025; the steepest drop was 221.66% in 2025.
• A 3-year view of Invested Capital shows it stood at -$177432.0 in 2024, then jumped by 4448.21% to $7.7 million in 2025, then jumped by 70.02% to $13.1 million in 2026.
• The last three Invested Capital figures came in at $13.1 million (Q1 2026), $7.7 million (Q4 2025), and $504019.0 (Q3 2025), per Business Quant data.